Filing Details
- Accession Number:
- 0000950170-24-028827
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-03-08 18:05:06
- Reporting Period:
- 2024-03-08
- Accepted Time:
- 2024-03-08 18:05:06
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1680581 | Fulcrum Therapeutics Inc. | FULC | Pharmaceutical Preparations (2834) | 474839948 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1916566 | Greg Tourangeau | C/O Fulcrum Therapeutics, Inc. 26 Landsdowne Street Cambridge MA 02139 | Vice President, Finance | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2024-03-08 | 4,884 | $11.72 | 11,807 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.71 to $11.74, inclusive. The reporting person undertakes to provide to Fulcrum Therapeutics, Inc., any security holder of Fulcrum Therapeutics, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.
- Includes 699 shares acquired under the Issuer's employee stock purchase plan on May 13, 2022.
Billionaire Hedge Funds
